Glenda C Marsh

Title: Glenda C Marsh: Innovator in Gastrointestinal Therapeutics

Introduction

Glenda C Marsh is a notable inventor based in Sao Paulo, Brazil. She has made significant contributions to the field of gastrointestinal therapeutics, particularly through her innovative patent that addresses the challenges of inducing satiety in patients.

Latest Patents

Marsh holds a patent for "Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods." This invention involves methods and devices that create an intestinal braking effect, which are non-invasive or minimally invasive, and may be reversible. The technology utilizes stabilized implantable systems and ingestible pills to achieve its therapeutic goals. One embodiment of her method includes accessing a patient's gastrointestinal tract and implanting an intraintestinal therapeutic substance eluting implant. This implant is designed to release a satiety-inducing substance, which can include nutrients, specific bio-active substances, pancreatic polypeptides, free fatty acids, cholecystokinin, amino acids, glutamine, lipids, linoleic acid, or combinations thereof, into the gastrointestinal tract.

Career Highlights

Glenda C Marsh is associated with Ethicon Endo-Surgery, Inc., where she continues to develop and refine her innovative approaches to gastrointestinal health. Her work has the potential to transform how patients manage their dietary needs and satiety.

Collaborations

Throughout her career, Marsh has collaborated with esteemed colleagues such as Thomas Edward Albrecht and Jeffrey L Aldridge. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Glenda C Marsh is a pioneering inventor whose work in gastrointestinal therapeutics exemplifies innovation in medical technology. Her contributions are poised to make a significant impact on patient care and dietary management.